Adenovirus-mediated expression of Fas ligand induces apoptosis of human prostate cancer cells

Cell Death and Differentiation

Volumn 6, Issue 2, 1999, Pages 175-182

  Hedlund, Tammy E ^a   Meech, Sandra J ^a   Srikanth, Sampathkumar ^a   Kraft, Andrew S ^a,b   Miller, Gary J ^a,b   Schaack, Jerome B ^a,b   Duke, Richard C ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO CANCER CENTER   (United States)

Author keywords

Adenovirus; Apoptosis; CD95; Cell death; Fas ligand; Gene therapy; Prostate; Prostate cancer; Recombinant adenovirus

Indexed keywords

FAS LIGAND;

ADENOVIRUS; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CROSS LINKING; CYTOTOXICITY; GENE EXPRESSION SYSTEM; GENE THERAPY; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE CANCER;

ADENOVIRIDAE; POXVIRIDAE;

EID: 0033057792     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400477     Document Type: Article

References (46)

1. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Seto Y and Nagata S (1991)The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233-243
2. Oehm A, Behrmann I, Falk W, Pawlita M, Maier G, Klas C, Li-Weber M, Richards S, Dhein J, Trauth BC and et al. (1992) Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. J. Biol. Chem. 267: 10709-10715
3. Suda T, Takahashi T, Golstein P and Nagata S (1993) Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75: 1169-1178
4. Nagata S and Golstein P (1995) The Fas death factor. Science 267: 1449-1456
5. Miyawaki T, Uehara T, Nibu R, Tsuji T, Yachie A, Yonehara S and Taniguchi N (1992) Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J. Immunol. 149: 3753-3758
6. Owen-Schaub LB, Yonehara S, Crump WLD and Grimm EA (1992) DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell. Immunol. 140: 197-205
7. Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A and Duke RC (1995) A role for CD95 ligand in preventing graft rejection. Nature 377: 630-632
8. Xerri L, Devilard D, Hassoun J, Mawas C and Birg F (1997) Fas ligand is not only expressed in immune privileged human organs but is also coexpressed with Fas in various epithelial tissues. Mol. Pathol. 50: 87-91
9. Leithauser F, Dhein J, Mechtersheimer G, KoretZ K, Bruderlein S, Henne C, Schmidt A, Debatin KM, Krammer PH and Moller P (1993) Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab. Invest. 69: 415-429
10. French LE, Hahne M, Viard I, Radlgruber G, Zanone R, Becker K, Muller C and Tschopp J (1996) Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues and characterized by apoptotic cell turnover. J. Cell Biol. 133: 335-343
11. Isaacs JT, Lundmo PI, Berges R, Martikainen P, Kyprianou N and English HF (1992) Androgen regulation of programmed death of normal and malignant prostatic cells. J. Androl. 13 457-464
12. Rotello RJ, Lieberman RC, Lepoff RB and Gerschenson LE (1992) Characterization of uterine epithelium apoptotic cell death kinetics and regulation by progesterone and RU 486. Am. J. Pathol. 140: 449-456
13. Suzuki A, Enari M, Eguchi Y, Matsuzawa A, Nagata S, Tsujimoto Y and Iguchi T (1996a) Involvement of Fas in regression of vaginal epithelia after ovariectomy and during an estrous cycle. EMBO J. 15: 211-215
14. Suzuki A, Matsuzawa A and Iguchi T (1996b) Down regulation of Bcl-2 is the first step on Fas-mediated apoptosis of male reproductive tract. Oncogene 13:31-37
15. Rokhlin OW, Bishop GA, Hostager BS, Waldschmidt TJ, Sidorenko SP, Pavloff N, Kiefer MC, Umansky SR, Glover RA and Cohen MB (1997) Fas-mediated apoptosis in human prostatic carcinoma cell lines. Cancer Res. 57:1758-1768
16. Uslu R, Borsellino N, Frost P, Garban H, Ng C, Mizutani Y, Belldegrun A and Bonavida B (1997) Chemosensitization of human prostate carcinoma cell lines to anti-Fas-mediated apoptosis. Clin. Cancer Res. 3: 963-972
17. Hedlund T, Duke R, Schleicher M and Miller G (1998) Fas-mediated apoptosis in seven human prostate cancer cell lines: correlation with tumor stage. Prostate 36: 92-101
18. Tewari M and Dixit VM (1995) Fas-and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product. J. Biol. Chem. 270: 3255-3260
19. Hedlund TE and Miller GJ (1994) A serum-free defined medium capable of supporting growth of four established human prostatic carcinoma cell lines. Prostate 24: 221-228
20. Lozzio C and Lozzio B (1975) Human chronic myelogenous leukemia cell line with positive Philadelphia chromosome. Blood 45: 321 -334
21. Graham FL, Smiley J, Russell WC and Nairn R (1977) Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36: 59-74
22. Duke RC, Newell E, Schleicher M, Meech S and Bellgrau D (1998) Transplantation of cells and tissues expressing Fas ligand. Transplantation Proc. (in press)
23. Jordan M, Schallhorn A and Wurm FM (1996) Transfecting mammalian cells: optimization of critical parameters affecting calcium-phosphate precipitate formation. Nucl. Acids Res. 24: 596-601
24. Rouvier E, Luciani MF and Golstein P (1993) Fas involvement in Ca(2+)-independentT cell-mediated cytotoxicity. J. Exp. Med. 177: 195-200
25. Zhang G, Gurtu V and Kain SR (1996) An enhanced green fluorescent protein allows sensitive detection of gene transfer in mammalian cells. Biochem. Biophys. Res. Commun. 227: 707-711
26. Gomez-Foix AM, Coats WS, Baque S, Alam T, Gerard RD and Newgard CB (1992) Adenovirus-mediated transfer of the muscle glycogen phosphorylase gene into hepatocytes confers altered regulation of glycogen metabolism. J. Biol. Chem. 267: 25129-25134
27. Schaack J, Langer S and Guo X (1995) Efficient selection of recombinant adenoviruses by vectors that express beta-galactosidase. J. Virol. 69: 3920-3923
28. Hardy S, Kitamura M, Harris-Stansil T, Dai Y and Phipps ML (1997) Construction of adenovirus vectors through Cre-lox recombination. J. Virol. 71: 1842-1849
29. Labarca C and Paigen K (1980) A simple, rapid, and sensitive DNA assay procedure. Analytical Biochemistry 102: 344-352
30. Duke R, Chervenak R and Cohen J (1983) Endogenous endonuclease-induced DNA fragmentation: An early event in cell-mediated cytolysis. Proc. Natl. Acad. Sci. USA 80: 6361-6365
31. McClinton S, Miller ID and Eremin O (1990) An immunohistochemical characterisation of the inflammatory cell infiltrate in benign and malignant prostatic disease. Brit. J. Cancer 61: 400-403
32. Wickham TJ, Mathias P, Cheresh DA and Nemerow GR (1993) Integrins alpha v beta 3 and alpah v beta 5 promote adenovirus internalization but not virus attachment. Cell 73: 309-319
33. Huang S, Kamata T, Takada Y, Ruggeri ZM and Nemerow GW (1996) Adenovirus interaction with distinct integrins mediates separate events in cell entry and gene delivery to hematopoietic cells. J. Virol. 70: 4502-4508
34. Witkowski CM, Rabinovitz I, Nagle RB, Affinito KS and Cress AE (1993) Characterization of integrin subunits, cellular adhesion and tumorgenicity of four human prostate cell lines. J. Cancer Res. Clin. Oncol. 119: 637-644
35. Haywood-Reid PL, Zipf DR and Springer WR (1997) Quantification of integrin subunits on human prostatic cell lines - comparison of nontumorigenic and tumorigenic lines. Prostate 31: 1-8
36. Muruve DA, Nicolson AG, Manfro RC, Strom TB, Sukhatme VP and Libermann TA (1997) Adenovirus-mediated expression of Fas ligand induces hepatic apoptosis after Systemic administration and apoptosis of ex vivo-infected pancreatic islet allografts and isografts. Hum. Gene Ther, 8: 955-963
37. Pajouh MS, Nagle RB, Breathnach R, Finch JD, Brawer MK and Bowden GT (1991) Expression of metalloproteinase genes in human prostate cancer. J. Cancer Res. Clin. Oncol. 117: 144-150
38. Roth BJ (1996) New therapeutic agents for hormone refractory prostate cancer. Sem. Oncol. 23: 49-55
39. Fife RS, Sledge GW and Proctor C (1997) Effects of vitamin D3 on proliferation of cancer cells in vitro. Cancer Lett. 120: 37-41
40. Suda T, Hashimoto H, Tanaka M, Ochi T and Nagata S (1997) Membrane Fas ligand kills human peripheral blood T lymphocytes and soluble Fas ligand blocks the killing. J. Exp. Med. 186: 2045-2050
41. Tanaka M, Itai T, Adachi M and Nagata S (1998) Downregulation of Fas ligand by shedding. Nature Med. 4: 31-36
42. Schneider P, Holler N, Bodmer JL, Hahne M, Frei K, Fontana A and Tschopp J (1998) Conversion of membrane-bound Fas (CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J. Exp. Med. 187: 1205-1213
43. Peitsch MC and Tschopp J (1995) Comparative molecular modelling of the Fas-ligand and other members of the TNF family. Mol. Immunol. 32: 761-772
44. Liu WY, Rubin MA, Omene C, Lederman S and Stein CA (1998) Fas ligand is constitutively secreted by prostate cancer cells in vitro. Clin. Cancer Res. 4: 1803-1811
45. Arai H, Gordon D, Nabel E and Nabel G (1997) Gene transfer of Fas ligand induces tumor regression in vivo. Proc. Natl. Acad. Sci. USA 94: 13862-13867
46. Schmid HP, McNeal JE and Stamey TA (1993) Observations on the doubling time of prostate cancer. The use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volume. Cancer 71: 2031-2040